Launched VIZZ™ (aceclidine ophthalmic solution) 1.44% in October 2025 for the treatment of presbyopia, with broad product ...

LENZ Therapeutics (LENZ) announced an exclusive distribution agreement for Lunatus to register and commercialize VIZZ for the ...

Multi-asset pipeline with significant targeted data readouts and milestones -- Two lead ophthalmic gene therapy programs in clinical trials ...

Exclusive distribution agreement includes revenue sharing in addition to upfront and milestone payments to LENZ ...

Launched VIZZ (aceclidine ophthalmic solution) 1.44% in October 2025 for the treatment of presbyopia, with broad product availability in mid-November 2025 Achieved approximately $1.6 million in net pr ...

Lake Oswego, OR - January 08, 2026 - PRESSADVANTAGE - At Tersigni Vision, a growing number of patients are asking ...

Opus Genetics (IRD) highlighted its progress achieved during 2025 and upcoming catalysts in 2026. OPGx-BEST1: First ...

RICHMOND HILL, ON, Jan. 7, 2026 /CNW/ - CooperVision Canada is proud to announce its sponsorship and partnership with Nikita ...

New Lenses Combine Advanced Silicone Hydrogel Material with Proven ActivControl Technology*1 to Slow the Worsening of Myopia ...

Euclid Vision Corporation (Euclid), a global leader in advanced orthokeratology (Ortho-K) lenses, diagnostic equipment and proactive myopia management initiatives, introduces Be Free® Day lens, a new ...

K2 Vision markets refractive lens exchange (RLE) as a long-term way to reduce dependence on glasses and readers by replacing ...

New Lenses Combine Advanced Silicone Hydrogel Material with Proven ActivControl® Technology*1 to Slow the Worsening of Myopia in Children†2,3 ...